Logan BK, Krotulski AJ
CDC “Overdose Data to Action” Recipient Meeting 2023CDC “Overdose Data to Action” Recipient Meeting: Meeting the Challenge – Making a Difference
Learning Themes
Attendees to this meeting will have an opportunity to expand skills and to learn from peers and national experts in the areas below. Learning will occur through plenary presentations, concurrent panels, skills-building workshops, and facilitated discussion forums with peers.
|
Learning Track |
Topic |
Thematic Material |
|
Surveillance |
Successes in the collection, analysis, and dissemination of syndromic and discharge data for nonfatal overdoses |
Anomaly detection, improvements to data quality/completeness, using DOSE data to inform prevention and overdose response efforts, state and local partnerships in nonfatal overdose surveillance, data trends over the course of the OD2A program; other DOSE successes and lessons learned. |
|
Surveillance |
Successes in the collection, analysis, and dissemination of fatal overdose data using SUDORS |
Anomaly detection, improvements to data quality/completeness, using SUDORS data to inform prevention and overdose response efforts, state and local partnerships in fatal overdose surveillance, other SUDORS successes and lessons learned. |
|
Surveillance |
Disseminating and using innovative surveillance data findings to inform prevention, planning, or response |
Surveillance of linkage to and retention in care, linking fatal and/or non-fatal data to other relevant medical or social service data sources, biosurveillance (testing specimens collected from overdose patients treated in emergency departments), collecting, sharing, and analyzing toxicologic results from drug products and paraphernalia to inform prevention, surveillance using EMS data. |
|
Surveillance |
Cross-cutting surveillance topics |
Using visualizations (e.g., dashboards, reports, other interactive products) of surveillance data to effectively drive overdose prevention and response, innovative automation to ease burden on staff, incorporating social determinants of health/health equity data in overdose surveillance, prevention and evaluation activities. |
PLATFORM PRESENTATION
